| Global incidence of neurological manifestations among patients hospitalized with COVID-19—a report for the GCS-NeuroCOVID consortium and the ENERGY consortium SHY Chou, E Beghi, R Helbok, E Moro, J Sampson, V Altamirano, ... JAMA network open 4 (5), e2112131-e2112131, 2021 | 376 | 2021 |
| Sex differences in movement disorders S Meoni, A Macerollo, E Moro Nature Reviews Neurology 16 (2), 84-96, 2020 | 157 | 2020 |
| Validation of the Italian version of the movement disorder society—unified Parkinson’s disease rating scale A Antonini, G Abbruzzese, L Ferini-Strambi, B Tilley, J Huang, ... Neurological Sciences 34, 683-687, 2013 | 140 | 2013 |
| Long-term outcomes (15 years) after subthalamic nucleus deep brain stimulation in patients with Parkinson disease F Bove, D Mulas, F Cavallieri, A Castrioto, S Chabardès, S Meoni, ... Neurology 97 (3), e254-e262, 2021 | 91 | 2021 |
| Pallidal deep brain stimulation for dystonia: a long term study S Meoni, V Fraix, A Castrioto, AL Benabid, E Seigneuret, L Vercueil, ... Journal of Neurology, Neurosurgery & Psychiatry 88 (11), 960-967, 2017 | 71 | 2017 |
| Predictors of long‐term outcome of subthalamic stimulation in Parkinson disease F Cavallieri, V Fraix, F Bove, D Mulas, M Tondelli, A Castrioto, P Krack, ... Annals of neurology 89 (3), 587-597, 2021 | 54 | 2021 |
| A phase II study to evaluate the safety and efficacy of prasinezumab in early Parkinson's disease (PASADENA): rationale, design, and baseline data G Pagano, FG Boess, KI Taylor, B Ricci, B Mollenhauer, W Poewe, ... Frontiers in neurology 12, 705407, 2021 | 52 | 2021 |
| Clinical perspectives of adaptive deep brain stimulation M Guidetti, S Marceglia, A Loh, IE Harmsen, S Meoni, G Foffani, ... Brain Stimulation 14 (5), 1238-1247, 2021 | 49 | 2021 |
| Dementia and subthalamic deep brain stimulation in Parkinson disease: a long-term overview F Bove, V Fraix, F Cavallieri, E Schmitt, E Lhommée, A Bichon, S Meoni, ... Neurology 95 (4), e384-e392, 2020 | 38 | 2020 |
| Long-term neuropsychiatric outcomes after pallidal stimulation in primary and secondary dystonia S Meoni, M Zurowski, AM Lozano, M Hodaie, YY Poon, M Fallis, V Voon, ... Neurology 85 (5), 433-440, 2015 | 35 | 2015 |
| Short‐and long‐term outcome and predictors in an international cohort of patients with neuro‐COVID‐19 E Beghi, R Helbok, S Ozturk, O Karadas, V Lisnic, O Grosu, T Kovács, ... European journal of neurology 29 (6), 1663-1684, 2022 | 26 | 2022 |
| COVID-19 and parkinsonism: a critical appraisal F Cavallieri, V Fioravanti, F Bove, E Del Prete, S Meoni, S Grisanti, ... Biomolecules 12 (7), 970, 2022 | 22 | 2022 |
| Visual dysfunction of the superior colliculus in de novo Parkinsonian patients E Moro, E Bellot, S Meoni, P Pelissier, R Hera, M Dojat, V Coizet, ... Annals of neurology 87 (4), 533-546, 2020 | 22 | 2020 |
| Deep brain stimulation: is it time to change gears by closing the loop? S Marceglia, M Guidetti, IE Harmsen, A Loh, S Meoni, G Foffani, ... Journal of Neural Engineering 18 (6), 061001, 2021 | 19 | 2021 |
| Axial impairment and falls in Parkinson’s disease: 15 years of subthalamic deep brain stimulation A Zampogna, F Cavallieri, F Bove, A Suppa, A Castrioto, S Meoni, ... NPJ Parkinson's disease 8 (1), 121, 2022 | 16 | 2022 |
| Asymmetric STN DBS for FOG in Parkinson's disease: a pilot trial S Meoni, B Debȗ, P Pelissier, E Scelzo, A Castrioto, E Seigneuret, ... Parkinsonism & related disorders 63, 94-99, 2019 | 16 | 2019 |
| Limbic serotonergic plasticity contributes to the compensation of apathy in early Parkinson's disease S Prange, E Metereau, A Maillet, H Klinger, E Schmitt, E Lhommée, ... Movement disorders 37 (6), 1211-1221, 2022 | 15 | 2022 |
| New players in basal ganglia dysfunction in Parkinson's disease S Meoni, RG Cury, E Moro Progress in brain research 252, 307-327, 2020 | 13 | 2020 |
| Surgical treatment of parkinson’s disease C Sidiropoulos, R Walsh, S Meoni, E Moro Current treatment options in neurology 14, 211-212, 2012 | 13 | 2012 |
| Advances in DBS technology and novel applications: focus on movement disorders SR Potel, S Marceglia, S Meoni, SK Kalia, RG Cury, E Moro Current Neurology and Neuroscience Reports 22 (9), 577-588, 2022 | 12 | 2022 |
